• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Pooling samples to increase testing capacity with Xpert Xpress SARS-CoV-2 during the Covid-19 pandemic in Lao People's Democratic Republ

tetano

Editor, Senior Moderator
PLoS One


. 2022 Sep 29;17(9):e0275294.
doi: 10.1371/journal.pone.0275294. eCollection 2022.
Pooling samples to increase testing capacity with Xpert Xpress SARS-CoV-2 during the Covid-19 pandemic in Lao People's Democratic Republic


Vibol Iem[SUP] 1 2 [/SUP], Phonepadith Xangsayarath[SUP] 3 [/SUP], Phonenaly Chittamany[SUP] 1 [/SUP], Sakhone Suthepmany[SUP] 1 [/SUP], Souvimone Siphanthong[SUP] 1 [/SUP], Phimpha Paboriboune[SUP] 4 [/SUP], Silaphet Somphavong[SUP] 5 [/SUP], Kontogianni Konstantina[SUP] 2 [/SUP], Jahangir A M Khan[SUP] 6 [/SUP], Thomas Edwards[SUP] 2 [/SUP], Tom Wingfield[SUP] 2 7 8 [/SUP], Jacob Creswell[SUP] 9 [/SUP], Jose Dominguez[SUP] 10 [/SUP], Luis E Cuevas[SUP] 2 [/SUP]



Affiliations
Free PMC article

Abstract

The COVID-19 pandemic created the need for large-scale testing of populations. However, most laboratories do not have sufficient testing capacity for mass screening. We evaluated pooled testing of samples, as a strategy to increase testing capacity in Lao PDR. Samples of consecutive patients were tested in pools of four using the Xpert Xpress SARS CoV-2 assay. Positive pools were confirmed by individual testing, and we describe the performance of the test and savings achieved. We also diluted selected positive samples to describe its effect on the assays CT values. 1,568 patients were tested in 392 pools of four. 361 (92.1%) pools were negative and 31 (7.9%) positive. 29/31 (93.5% (95%CI 77-99%) positive pools were confirmed by individual testing of the samples but, in 2/31 (6.5%) the four individual samples were negative, suggesting contamination. Pools with only one positive sample had higher CT values (lower RNA concentrations) than the respective individual samples, indicating a dilution effect, which suggested an increased risk of false negative results with dilutions >1:10. However, this risk may be low if the prevalence of infection is high, when pools are more likely to contain more than one positive sample. Pooling saved 67% of cartridges and substantially increased testing capacity. Pooling samples increased SARS-CoV-2 testing capacity and resulted in considerable cartridge savings. Given the need for high-volume testing, countries may consider implementation of pooling for SARS-CoV-2 screening.
 
Back
Top Bottom